Viatris Inc (VTRS)
13.37
+0.12
(+0.91%)
USD |
NASDAQ |
Nov 22, 16:00
13.38
0.00 (0.00%)
After-Hours: 20:00
Viatris Free Cash Flow: 1.893B for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.893B |
| June 30, 2024 | 1.884B |
| March 31, 2024 | 2.000B |
| December 31, 2023 | 2.325B |
| September 30, 2023 | 2.023B |
| June 30, 2023 | 2.045B |
| March 31, 2023 | 2.332B |
| December 31, 2022 | 2.510B |
| September 30, 2022 | 2.835B |
| June 30, 2022 | 3.035B |
| March 31, 2022 | 2.778B |
| December 31, 2021 | 2.508B |
| September 30, 2021 | 1.784B |
| June 30, 2021 | 1.296B |
| March 31, 2021 | 1.166B |
| December 31, 2020 | 550.60M |
| September 30, 2020 | 1.539B |
| June 30, 2020 | 1.502B |
| March 31, 2020 | 1.686B |
| December 31, 2019 | 1.398B |
| September 30, 2019 | 1.022B |
| June 30, 2019 | 1.187B |
| March 31, 2019 | 789.20M |
| December 31, 2018 | 1.146B |
| September 30, 2018 | 1.270B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.098B |
| March 31, 2018 | 1.101B |
| December 31, 2017 | 1.169B |
| September 30, 2017 | 888.80M |
| June 30, 2017 | 1.533B |
| March 31, 2017 | 1.690B |
| December 31, 2016 | 1.297B |
| September 30, 2016 | 1.68B |
| June 30, 2016 | 1.180B |
| March 31, 2016 | 854.80M |
| December 31, 2015 | 1.139B |
| September 30, 2015 | 776.60M |
| June 30, 2015 | 265.50M |
| March 31, 2015 | 409.90M |
| December 31, 2014 | 269.30M |
| September 30, 2014 | 493.70M |
| June 30, 2014 | 735.30M |
| March 31, 2014 | 747.70M |
| December 31, 2013 | 711.10M |
| September 30, 2013 | 496.36M |
| June 30, 2013 | 601.32M |
| March 31, 2013 | 736.32M |
| December 31, 2012 | 563.30M |
| September 30, 2012 | 680.76M |
| June 30, 2012 | 505.32M |
Free Cash Flow Range, Past 5 Years
550.60M
Minimum
Dec 2020
3.035B
Maximum
Jun 2022
1.954B
Average
1.947B
Median
Free Cash Flow Benchmarks
| Lexicon Pharmaceuticals Inc | -208.39M |
| Moderna Inc | -3.956B |
| Baxter International Inc | 391.00M |
| Gilead Sciences Inc | 9.431B |
| Perspective Therapeutics Inc | -40.58M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 826.50M |
| Cash from Investing (Quarterly) | 1.748B |
| Cash from Financing (Quarterly) | -1.637B |
| Free Cash Flow Per Share (Quarterly) | 0.6174 |
| Free Cash Flow to Equity (Quarterly) | 2.090B |
| Free Cash Flow to Firm (Quarterly) | 893.62M |
| Free Cash Flow Yield | 11.77% |